<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02783911</url>
  </required_header>
  <id_info>
    <org_study_id>5140262</org_study_id>
    <nct_id>NCT02783911</nct_id>
  </id_info>
  <brief_title>Comparison of Mineral Trioxide Aggregate (MTA) &amp; Ferric Sulfate (FS) Pulpotomies</brief_title>
  <official_title>Comparison of Clinical and Radiographic Success Between Mineral Trioxide Aggregate (MTA) &amp; Ferric Sulfate (FS) Pulpotomies for Primary Molars</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of clinical and radiographic success between Mineral Trioxide Aggregate and Ferric&#xD;
      Sulfate pulpotomies for primary molars. Recall appointments are completed 6 months, 9 months&#xD;
      and 12 months.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison of clinical and radiographic success between Mineral Trioxide Aggregate and Ferric&#xD;
      Sulfate pulpotomies for primary molars. Recall appointments are completed 6 months, 9 months&#xD;
      and 12 months. Regular recall and follow up will be performed for patients who has MTA or FS&#xD;
      pulpotomies. Clinical and radiographic findings will be recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The resident graduated.&#xD;
  </why_stopped>
  <start_date type="Actual">January 29, 2015</start_date>
  <completion_date type="Actual">March 14, 2017</completion_date>
  <primary_completion_date type="Actual">March 14, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the Clinical Success Between Mineral Trioxide Aggregate (MTA) &amp; Ferric Sulfate (FS) Pulpotomies in Primary Molars</measure>
    <time_frame>1 year</time_frame>
    <description>At recall visits 6,9,12 months, blinded clinical examination will be completed by participating faculty members who are calibrated to clinical scaring criteria. Periapical radiographs will be taken and evaluated by 2 pediatric dentists and 1 endodontist, for presence of various pathologies. Scored based on the criteria established by Zurn and Seale 2008. Scores will be transferred to Microsoft Excel. The difference between the two materials will be analyzed using the Mann-Whiteney U test, chi-square test and Fisher's exact test. Intra- and inter-rater agreement will be measured for radiographic assessment using Cohen's kappa test</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Primary Teeth</condition>
  <condition>Pulpotomy</condition>
  <arm_group>
    <arm_group_label>Mineral Trioxide Aggregate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject with pulpotomy treated with MTA MTA paste (&lt; 1gm) will be placed on pulp orifice once for the life of the primary teeth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ferric Sulfate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject with pulpotomy treated with FS FS paste (&lt;1gm) will placed on pulp orifice once for 15 secs and removed on primary teeth</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MTA</intervention_name>
    <description>Mineral Trioxide Aggregate grey paste</description>
    <arm_group_label>Mineral Trioxide Aggregate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ferric Sulfate</intervention_name>
    <description>Ferric Sulfate paste</description>
    <arm_group_label>Ferric Sulfate</arm_group_label>
    <other_name>FS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA I,II&#xD;
&#xD;
          -  Primary Molars diagnosed with normal or reversible pulpitis with vital carious pulp&#xD;
             exposures&#xD;
&#xD;
          -  Teeth that can have hemostasis can be achieved with pressure&#xD;
&#xD;
          -  No clinical symptoms&#xD;
&#xD;
          -  No radiographic signs of internal resorption or external root resorption&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Primary Molars diagnosed with irreversible pulpitis or necrotic pulp&#xD;
&#xD;
          -  Teeth that can not achieve hemostasis&#xD;
&#xD;
          -  Teeth with abscess or fistula&#xD;
&#xD;
          -  Teeth that have radiographic signs of internal resorption or external resorption&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jung-Wei Chen, DDS,MS,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda University</affiliation>
  </overall_official>
  <reference>
    <citation>Asgary S, Shirvani A, Fazlyab M. MTA and ferric sulfate in pulpotomy outcomes of primary molars: a systematic review and meta-analysis. J Clin Pediatr Dent. 2014 Fall;39(1):1-8. Review.</citation>
    <PMID>25631717</PMID>
  </reference>
  <results_reference>
    <citation>Yildirim C, Basak F, Akgun OM, Polat GG, Altun C. Clinical and Radiographic Evaluation of the Effectiveness of Formocresol, Mineral Trioxide Aggregate, Portland Cement, and Enamel Matrix Derivative in Primary Teeth Pulpotomies: A Two Year Follow-Up. J Clin Pediatr Dent. 2016 Winter;40(1):14-20. doi: 10.17796/1053-4628-40.1.14.</citation>
    <PMID>26696101</PMID>
  </results_reference>
  <results_reference>
    <citation>Stringhini Junior E, Vitcel ME, Oliveira LB. Evidence of pulpotomy in primary teeth comparing MTA, calcium hydroxide, ferric sulphate, and electrosurgery with formocresol. Eur Arch Paediatr Dent. 2015 Aug;16(4):303-12. doi: 10.1007/s40368-015-0174-z. Epub 2015 Apr 2. Review.</citation>
    <PMID>25833280</PMID>
  </results_reference>
  <results_reference>
    <citation>Frenkel G, Kaufman A, Ashkenazi M. Clinical and radiographic outcomes of pulpotomized primary molars treated with white or gray mineral trioxide aggregate and ferric sulfate--long-term follow-up. J Clin Pediatr Dent. 2012 Winter;37(2):137-41.</citation>
    <PMID>23534318</PMID>
  </results_reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 18, 2016</study_first_submitted>
  <study_first_submitted_qc>May 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2016</study_first_posted>
  <results_first_submitted>March 11, 2021</results_first_submitted>
  <results_first_submitted_qc>May 17, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">June 11, 2021</results_first_posted>
  <last_update_submitted>May 17, 2021</last_update_submitted>
  <last_update_submitted_qc>May 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loma Linda University</investigator_affiliation>
    <investigator_full_name>Jung-Wei Chen, DDS, MS, PhD</investigator_full_name>
    <investigator_title>Pediatric Dental Director</investigator_title>
  </responsible_party>
  <keyword>Clinical and Radiograph</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 2, 2014</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/11/NCT02783911/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 2, 2014</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/11/NCT02783911/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 9, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/11/NCT02783911/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>3-10 years old, deep caries, No radiographic signs of internal/external root resorption, No pathology change, no swelling or abscess.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Mineral Trioxide Aggregate</title>
          <description>Subject with pulpotomy treated with MTA MTA paste (&lt; 1gm) will be placed on pulp orifice once for the life of the primary teeth&#xD;
MTA: Mineral Trioxide Aggregate grey paste</description>
        </group>
        <group group_id="P2">
          <title>Ferric Sulfate</title>
          <description>Subject with pulpotomy treated with FS FS paste (&lt;1gm) will placed on pulp orifice once for 15 secs and removed on primary teeth&#xD;
Ferric Sulfate: Ferric Sulfate paste</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="46"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>some participants has more than one tooth needs pulpotomy treatment</population>
      <group_list>
        <group group_id="B1">
          <title>Mineral Trioxide Aggregate</title>
          <description>Subject with pulpotomy treated with MTA MTA paste (&lt; 1gm) will be placed on pulp orifice once for the life of the primary teeth&#xD;
MTA: Mineral Trioxide Aggregate grey paste</description>
        </group>
        <group group_id="B2">
          <title>Ferric Sulfate</title>
          <description>Subject with pulpotomy treated with FS FS paste (&lt;1gm) will placed on pulp orifice once for 15 secs and removed on primary teeth&#xD;
Ferric Sulfate: Ferric Sulfate paste</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
            <count group_id="B2" value="46"/>
            <count group_id="B3" value="57"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="11"/>
                    <count group_id="B2" value="46"/>
                    <count group_id="B3" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Months</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="11"/>
                    <count group_id="B2" value="46"/>
                    <count group_id="B3" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73.9" spread="16.9"/>
                    <measurement group_id="B2" value="81.3" spread="19.9"/>
                    <measurement group_id="B3" value="78.5" spread="18.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="11"/>
                    <count group_id="B2" value="46"/>
                    <count group_id="B3" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>patient has deep caries</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="11"/>
                    <count group_id="B2" value="46"/>
                    <count group_id="B3" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Comparison of the Clinical Success Between Mineral Trioxide Aggregate (MTA) &amp; Ferric Sulfate (FS) Pulpotomies in Primary Molars</title>
        <description>At recall visits 6,9,12 months, blinded clinical examination will be completed by participating faculty members who are calibrated to clinical scaring criteria. Periapical radiographs will be taken and evaluated by 2 pediatric dentists and 1 endodontist, for presence of various pathologies. Scored based on the criteria established by Zurn and Seale 2008. Scores will be transferred to Microsoft Excel. The difference between the two materials will be analyzed using the Mann-Whiteney U test, chi-square test and Fisher's exact test. Intra- and inter-rater agreement will be measured for radiographic assessment using Cohen's kappa test</description>
        <time_frame>1 year</time_frame>
        <population>The patients who came back for follow up for long term clinical and radiographic success.</population>
        <group_list>
          <group group_id="O1">
            <title>Mineral Trioxide Aggregate</title>
            <description>Subject with pulpotomy treated with MTA MTA paste (&lt; 1gm) will be placed on pulp orifice once for the life of the primary teeth&#xD;
MTA: Mineral Trioxide Aggregate grey paste</description>
          </group>
          <group group_id="O2">
            <title>Ferric Sulfate</title>
            <description>Subject with pulpotomy treated with FS FS paste (&lt;1gm) will placed on pulp orifice once for 15 secs and removed on primary teeth&#xD;
Ferric Sulfate: Ferric Sulfate paste</description>
          </group>
        </group_list>
        <measure>
          <title>Comparison of the Clinical Success Between Mineral Trioxide Aggregate (MTA) &amp; Ferric Sulfate (FS) Pulpotomies in Primary Molars</title>
          <description>At recall visits 6,9,12 months, blinded clinical examination will be completed by participating faculty members who are calibrated to clinical scaring criteria. Periapical radiographs will be taken and evaluated by 2 pediatric dentists and 1 endodontist, for presence of various pathologies. Scored based on the criteria established by Zurn and Seale 2008. Scores will be transferred to Microsoft Excel. The difference between the two materials will be analyzed using the Mann-Whiteney U test, chi-square test and Fisher's exact test. Intra- and inter-rater agreement will be measured for radiographic assessment using Cohen's kappa test</description>
          <population>The patients who came back for follow up for long term clinical and radiographic success.</population>
          <units>tooth</units>
          <param>Count of Units</param>
          <units_analyzed>tooth</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>tooth</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Clinical success</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Clinical fail</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.808</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <desc>Any untoward or unfavorable medical occurrence in a participant, including any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the participant's participation in the research, whether or not considered related to the participant's participation in the research.</desc>
      <group_list>
        <group group_id="E1">
          <title>Mineral Trioxide Aggregate</title>
          <description>Subject with pulpotomy treated with MTA MTA paste (&lt; 1gm) will be placed on pulp orifice once for the life of the primary teeth&#xD;
MTA: Mineral Trioxide Aggregate grey paste</description>
        </group>
        <group group_id="E2">
          <title>Ferric Sulfate</title>
          <description>Subject with pulpotomy treated with FS FS paste (&lt;1gm) will placed on pulp orifice once for 15 secs and removed on primary teeth&#xD;
Ferric Sulfate: Ferric Sulfate paste</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jung-Wei Chen, Program director</name_or_title>
      <organization>LomaLindaU</organization>
      <phone>9095584690 ext 85909</phone>
      <email>jwchen@llu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

